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Abstract
Background: Malnutrition and inflammation are associated with morbidity and mortality 
in patients on maintenance hemodialysis (MHD). Ghrelin, an orexigenic peptide hormone, 
is speculated to be associated with nutritional and inflammatory status in MHD. Aim: To 
assess the serum total ghrelin levels and its possible relationship with inflammation and 
nutritional status in patients on MHD. Subjects and Methods: The study was conducted on 
90 patients on MHD for 6 months and above (56 males, 34 females, mean age 52.6 [11.7] 
years; mean dialysis vintage 20.9 [12.1] months) and 70 healthy volunteers as control (5 males, 
25 females, mean age 50.6 [9.7] years). Demographics were obtained for the study population, 
and dialysis‑related data were collected for cases. Anthropometry, biochemical parameters, 
serum total ghrelin and inflammatory markers tumor necrosis factor‑alpha (TNF‑α), 
and high‑sensitivityC‑reactive protein (hsCRP) were assessed for cases and control. 
Self‑reported appetite (five questions of appetite and diet assessment tool) and nutritional 
status (subjective global assessment‑dialysis malnutrition score) were assessed for cases. 
Results: Ghrelin (242.5 [62.3] pg/mL vs. 80.2 [19.6] pg/mL; P < 0.001), TNF‑α (39.8 [15.2] 
pg/mL vs. 6.5 [1.2] pg/mL; P < 0.001), hsCRP (10.2 [2.8] mg/L vs. 2.7 [0.54] mg/L; P < 0.001) 
were significantly elevated in cases versus control, anthropometry, and biochemical parameters 
were significantly decreased in hemodialysis patient. Of 90 cases, (13/90 [14.4%]) were 
well‑nourished, (28/90 [31%]) mild to moderately malnourished, and (49/90 [54.4%]) were 
moderate to severely malnourished. Appetite was very good for14.4%, good and fair for 47.8%, 
poor and very poor for 37.8% patients. There was a significant difference in appetite with 
respect to nutritional status (P < 0.001). Ghrelin had positive correlation with inflammatory 
markers and negative correlation with nutritional status (P < 0.001). Conclusion: The study 
identified the association of ghrelin with appetite, nutritional, and inflammatory status of 
the patients on MHD.
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Introduction
Protein-energy malnutrition (PEM) is the state of decreased 
body pools of protein with or without fat depletion or decline 
in functional capacity, induced partly by inadequate nutrient 
intake relative to nutrient demand and/or which is improved 
by nutritional repletion. PEM is a common phenomenon in 
maintenance dialysis patients, a majorrisk factor for poor 
quality of life andincreased morbidity and mortality inclusive 
of cardiovascular death.[1] Various studies have established 
the prevalence of PEM between 18% and 75% in patients 
undergoing chronic hemodialysis.[2,3]
The causes of malnutrition in dialysis patients are 
multifactorial. Appetite, i.e., the subjective desire to ingest 
food, is diminished in many dialysis patients.[3] Anorexia 
or loss of desire to eat contributes largely to malnutrition 
and affects thequality of life in hemodialysis patients.[4]
As the disease progresses, anorexia also increases and 
lead to metabolic disturbances, protein-energy wasting, 
cachexia all resulting in high rates of morbidity and 
mortality. The pathogenesis of anorexia in hemodialysis 
is essentially unknown. It was proposed that uremic 
toxins (e.g., middle molecules, proinflammatory cytokines, 
altered amino acids, hormones (e.g., leptin and ghrelin), and 
neuropeptides (e.g., neuropeptide Y [NPY], peptide [P]) are 
involved.[5]
PEM often overlaps with inflammation leading to 
malnutrition-inflammation syndrome. The key role in 
these events is played by proinflammatory cytokines 
such as interleukins-1 (IL-1), IL-6, and tumor necrosis 
factor-alpha (TNF-α). A strong and consistent association 
between anorexia and high levels of inflammatory markers has 
been shown in previous studies. Cytokines may inhibit feeding 
by causing not only nausea and vomiting but also decreased 
gastric motility and emptying or by modifying gastric acid 
secretion.[6,7]
Ghrelin is a recently identified 28 amino acid peptide hormone 
which is produced by the endocrine cells of the stomach. It was 
the first peripheral orexigenic hormone identified.[8,9] Ghrelin 
is presently regarded as the only known circulating orexigen 
and exerts antagonistic effects on the leptin-induced decrease 
in food intake through activation of the hypothalamic NPY-Y1 
pathway.Ghrelin is released under conditions of negative 
energy balance and is an initiating signal for food intake. 
Ghrelin and its receptor are expressed in the arcuate nucleus 
of the hypothalamus, a potent appetite controlling center. 
A recent study reported the presence of ghrelin in previously 
uncharacterized hypothalamic neurons adjacent to the third 
ventricle. These ghrelin-containing neurons send efferent 
fibers to neurons that contain NPY and agouti‑related peptide 
and may stimulate the release of these orexigenic peptides and 
suppress the release of pro-opiomelanocortin, which inhibits 
food intake.[10-12]
Ghrelin increases food intake and was reported to be elevated 
in patients with chronic kidney disease (CKD). Conflicting 
results of circulating ghrelin levels in CKD have been 
presented. Elevated plasma ghrelin levels were observed in 
adult dialysis patients than those of age-matched controls.[13-15]
Yoshimoto et al. reported 2.8-fold higher ghrelin and desacyl 
ghrelin levels in patients with renal failure, but data on the 
association between ghrelin levels and body composition in 
end-stage renal disease (ESRD) patients has not been much 
reported in the literature.[16]
Likewise, though some studies have reported a strong 
association between ghrelin and inflammatory markers in 
endotoxemic dogs,[17] little is known about the function and 
levels of ghrelin during inflammation. Studies of ghrelin levels 
appear to be important in maintenance hemodialysis (MHD) 
patients because ghrelin may be implicated in the appetite 
dysregulation, inflammation, and malnutrition, which are 
interlinked and are frequently observed in these patients. 
Hence, a study was conducted to characterize the serum total 
ghrelin levels and its relation with nutritional and inflammatory 
status in patients undergoing chronic hemodialysis.
Subjects and Methods
A case–control study was conducted for a period of 
1 year (September 2013 to August 2014), after obtaining the 
approval of the Institutional Ethics Committee and the consent 
of the study participants.
Study population
Cases
Patients undergoing MHD were continuously screened for 
eligibility as per the following criterion. About 90 patients 
with eligibility criteria and consented to participate in the study 
were included as case population.
Inclusion criteria
• Patients above 18 years of age, undergoing hemodialysis 
for at least 6 months
• Patients on oral diet
• Patients undergoing twice/thrice weekly MHD.
Exclusion criteria
• Patients with chronic systemic inflammatory diseases, 
smoking history, and known malignancies
• Patients with acute illness and overt infectious complications
• Patients on concurrent use of glucocorticoids and other 
immunosuppressive agents
• Patients on enteral or parenteral nutrition.
Control
A population-based group of 70 subjects of either sex, aged 
above 18 years, with no known significant health problems or 
illness and are confirmed to be medically fit, who accepted to 
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participate as volunteers were randomly selected and included 
as controls for comparative reasons.
Sample size was calculated based on the literature.[18,19] The 
expected alpha error probability to detect the difference in 
mean serum ghrelin levels between hemodialysis patients 
and healthy controls was estimated to be about 0.05, and the 
assumed odds ratio was 5. Assuming 95% confidence level 
and 81% power, the minimum sample size required was 70 
per arm (70 cases and 70 controls, total = 140). The calculated 
sample size of the case population was 90 (15% increase in 
the sample size than the control) in order to evade attrition.
Data collection
A detailed history elucidation including the demographic 
data (age, sex, weight in kg, height in cm), were obtained 
for both cases and control. Further details on comorbidities, 
pre-and post-dialytic blood pressure, duration of dialysis, total 
number of dialysis sessions, interdialytic weight gain, and 
ultrafiltration (L) were obtained from the patients’ medical 
records. The dialysis adequacy (Kt/V) was determined from 
pre-and post-dialytic blood urea nitrogen (BUN) levels and 
the pre-and post-dialysis weights as described byDaugirdas.[20] 
The normalized protein catabolic rate (nPCR) was estimated 
using a simple formula:[7] nPCR (g/kg/day) = (0.0136 × [Kt/V 
× ([predialysis BUN + postdialysis BUN]/2)]) +0.251. The 
urea reduction rate (URR) was calculated using the formula:[21] 
100 (1post-BUN/pre-BUN).
Blood sample collection
To execute the study specific investigations, 5 mL of venous 
blood samples were collected from the case and the control 
groups after overnight fast, placed in appropriate tubes 
for separation of serum, and then stored at −70°C until 
analyzed for serum ghrelin and inflammatory cytokines 
TNF-α and high-sensitivity C-reactive protein (hsCRP) 
levels. For the case group, the blood samples were obtained 
before the initiation of the dialysis session.Estimation of the 
following was done using commercial kits according to the 
manufacturer’s instructions:
• Serum ghrelin by enzyme‑linked immunosorbent 
assay (ELISA) using DRG International, Inc., USA, human 
ghrelin (total) ELISA Kit. The minimum detectable dose 
of ghrelin was 30 pg/mL
• Serum TNF‑α by ELISA using DRG International, Inc., 
USA. Human TNF-α ELISA Kit. The minimum detectable 
dose of TNF-α is typically <12 pg/mL
• Serum hsCRP by immunoturbidimetric method using 
Daiichi kit (Daiichi pure Chemicals Co. Ltd., Tokyo, 
Japan).
The other biochemical parameters estimated for the case and 
the control groups included hemoglobin, packed cell volume, 
BUN (pre- and post-dialytic levels for cases), creatinine, 
albumin, total protein, and globulin. Further for the case group 
alone, serum iron, ferritin, transferrin, and total iron binding 
capacity (TIBC) were also obtained and all done by routine 
laboratory methods.
The anthropometric measurements were performed for both 
case and the control groups (between 10 and 20 min after 
termination of dialysis session for the cases), and the following 
assessments were done to obtain the body composition. The 
assessments were made by the same individual with the 
guidance of the clinical nutritionist using the same equipment 
to avoid errors during measurement:
• Body mass index (BMI)[22] – calculated using the formula 
body weight in kg/height in m2. In cases, dry body 
weight (the weight obtained by the end of dialysis without 
causing hypotension and/or cramps) was considered for 
calculation of BMI
• Mid‑arm circumference (MAC)[23] – measured with a 
plastic tape (on the nondialysis access arm for cases) for 
3 times and average result of the three measurements was 
taken as final result
• Triceps skin fold thickness (TSF)[23] – measured with 
a conventional skinfold caliper (Harpenden calipers) 
using standard techniques (on the nondialysis access 
arm for cases) for 3 times and average result of the three 
measurements was taken as final result
• Mid‑arm muscle circumference (MAMC)[23] was calculated 
from the formula:
 MAMC = MAC −(3.1416 × TSF)
• Mid‑arm muscle area (MAMA)[23] is an estimation of the 
area of the bone and muscle portions of the upper arm. It 
was calculated using the formula:
 MAMA = (MAC [cm] –[30.14 × TSFcm]) 2 – 10 (males) 
or – 6.5 (females) ∕ 4π
• Mid‑arm fat area (MAFA):[24]
 MAFA = (MAC × TSF)/2− π (TSF) 2/4
• Lean body mass (LBM)[25] is an estimation of difference 
between the total body mass (weight in kg) and weight of 
the body fat. LBM was obtained using the formula:
 LBM in kg (men) = (1.10 × weight [kg]) −128 
× (weight2/[100 × height (m) 2)
 LBM in kg (women) = (1.07 × weight [kg) −148 
× (weight2/[100 × height (m)]2)
• Ideal body weight (IBW) was calculated using Devine 
formula:[26]
 IBW in kg (men) =50 kg + 2.3 kg × (height [in] −60)
 IBW in kg (women) =45.5 kg + 2.3 kg × (height [in] 
−60)
• Total body water (TBW) gives the urea volume of 
distribution. It was calculated from the formula by Watson 
et al.:[27]
 Male TBW (Liters) =2.447− (0.09156 × age) 
+ (0.1074 × height) + (0.3362 × weight)
 Female TBW (Liters) = −2.097+ (0.1069 × height) 
+ (0.2466 × weight)
• Fat‑free mass (FFM): Calculated as follows:[28]
 FFM = TBW/0.72.
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• Total body fat (TBF): Calculated as follows:[28]
 TBF (kg) = Weight − FFM
Nutritional and appetite assessments in case 
population
The case group alone was subjected to five questions of appetite 
and diet assessment tool (ADAT)[29] for the assessment of 
self-reported appetite and subjective global assessment-dialysis 
malnutrition score (SGA-DMS)[30] for the assessment of 
nutritional status. These questionnaires were answered by the 
cases either at the time of or within a week of blood sample 
collection. The questionnaires were answered independently by 
the patients after explanation of those tools by the investigator. 
Those who required assistance were assisted by the investigator.
ADAT is a 44 item, self-administered questionnaire divided 
into three sections. Questions are about the patient’s general 
level of appetite, recent changes in dry weight, dietary 
compliance, need for assistance with food shopping and 
meal preparation, common food practices, and the patient’s 
perceptions of food enjoyment and diet satisfaction. The 
answers to the appetite questions are scored as (1) very good, 
(2) good, (3) fair, (4) poor, and (5) very poor, based on Likert 
five‑point grading scale. Five questions of ADAT are directly 
related to appetite. The first question focuses on self‑rating 
of the appetite during the past week. The second and third 
questions focus on the change in appetite in the past week and 
if so, had appetite increased, remained the same or decreased. 
The fourth and the fifth questions focus on the appetite levels 
of the patients on dialysis and non-dialysis days respectively. 
The study patients were made to answer the five questions of 
the ADAT, and the appetite levels of the study patients were 
graded based on their response. Based on their appetite status, 
patients were categorized into three groups as very good, good, 
and fair, poor and very poor.
As the ADAT questionnaire was not used in the Indian 
population to our knowledge, the consistency and the internal 
reliability of the ADAT questionnaire in the study population 
was assessed by Cronbach’s alpha, and a value of 0.732 was 
obtained (a value of above 0.6 indicated high internal reliability 
of the scales).
SGA-DMS is a fully quantitative scoring system consisting of 
seven features: Weight change, dietary intake, gastrointestinal 
symptoms, functional capacity, comorbidity, subcutaneous fat, 
and signs of muscle wasting. Each component has a score from 
1(normal) to 5 (very severe). Thus, the malnutrition score (sum 
of all seven components) is a number between 7 (normal) and 
35 (severely malnourished). Therefore, a lower score denotes 
tendency toward normal nutritional status. A higher score, 
however, is considered to be an indicator of the presence of 
malnutrition elements that is the higher the nutritional score the 
stronger the tendency toward protein calorie malnutrition. In 
the present study, patients with a score of 7–10 were considered 
as well-nourished, 11–20 as mild to moderately malnourished, 
and 21–35 as moderate to severely malnourished.
Statistical tests
The analysis was performed using Statistical Package for Social 
Sciences, (SPSS, Version 16.0, Chicago, IL, USA). Categorical 
variables were expressed as frequency and percentage and 
continuous variables were expressed as mean (standard 
deviation). Independent t-test was used to analyze the statistical 
difference in serum levels of ghrelin and inflammatory 
markers TNF-α, hsCRP, anthropometry, and other biochemical 
parameters between case and control population. The statistical 
analysis of differences in anthropometric and biochemical data, 
serum levels of ghrelin, and inflammatory markers TNF‑α and 
hsCRP in case population with respect to their appetite status 
as per ADAT and nutritional status as per SGA-DMS were 
done using one‑way analysis of variance with Tukey’s post hoc 
test. Pearson’s correlation was used to analyze the association 
between serum ghrelin concentrations, inflammatory markers, 
and nutritional status. A P < 0.05 was considered statistically 
significant.
Results
Characteristics of the study population
The study was conducted in 90 patients (55/90 [61%] males 
and 35/90 [39%] females) undergoing twice/thrice weekly 
MHD and 70 healthy volunteers as control (45/70 [64%] males 
and 23/70 [36%] females). The age range of the cases was 
18–73 years and the mean age was 52.6 (11.7) years. Similarly, 
the age range of the control was 19–67 years and the mean 
age was 50.4 (10.3) years. Majority of the study subjects were 
in the age range of 46–65 years (65/90 [68.9%] in cases and 
45/70 [66.8%] in control). There was no significant difference 
in the age (P = 0.74) and gender distribution (P = 0.22) of 
the case and the control population [Table 1]. The primary 
causes of renal disease cases were diabetic nephropathy 
in (39/90 [43.3%]) patients, hypertensive nephropathy 
in (27/90 [30%]), polycystic kidney disease in (11/90 [12.2%]), 
glomerulonephritis in (9/90 [10%]), pyelonephritis in (3/90 
[3.4%]), and neurogenic bladder in (1/90 [1.1%]) patients.








Males 55 (61) 45 (64) 100
Females 35 (39) 25 (36) 60 0.74 (NS)
Age range (years)
≤35 8 (8.9) 7 (10) 15 (9.4) 0.22 (NS)
36‑45 9 (10) 14 (20) 23 (14.4)
46‑55 35 (38.9) 20 (28.6) 55 (34.4)
56‑65 27 (30) 25 (35.7) 52 (32.4)
>65 11 (12.2) 4 (5.7) 15 (9.4)
Mean age in 
years (SD)
52.6 (11.7) 50.43 (10.3) ‑
n: Number of subjects, NS: Nonsignificant, SD: Standard deviation
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Dialysis data of the case group
The mean dialysis vintage of the cases was found to be 23 (12.1) 
months. The mean interdialytic weight gain was found to be 
3.1 (1.2) kg. The mean pre- and post-dialytic systolic blood 
pressure was 149.2 (12.1) and 134.8 (11.5) mm Hg, and the 
mean pre- and post-dialytic diastolic blood pressure was 
88.7 (6.1) and 82.2 (6.4) mmHg, respectively. The pre- and 
post-dialytic BUN was 120.2 (36) and 40.2 (12.2) mg/dL, 
respectively. The mean dialysis adequacy (Kt/V) was found 
to be 1.38 (0.09) and mean (nPCR g/kg/day) was 1.76 (0.5). 
The mean URR was found to be 66.4 (2.4).
Anthropometric parameters of cases and control
Table 2 depicts the anthropometric parameters of cases and 
control. The mean values of the anthropometric indices were 
decreased in the case group when compared to the control, and 
the difference was statistically significant (P < 0.001). The IBW 
was also lesser for the cases when compared to the control, 
but the difference was not statistically different (P = 0.19).
Biochemical parameters of cases and control
Table 3 depicts the biochemical parameters of the study 
population. The levels of serum hemoglobin, packed 
cell volume, creatinine, estimated glomerular filtration 
rate (eGFR), albumin, and total protein were found to be 
significantly higher in the cases when compared to the control, 
whereas the hemoglobin, packed cell volume, albumin, and the 
total protein levels were significantly lower in the cases than 
the control (P < 0.001). There was no difference in the serum 
globulin levels between the case and the control population.
Serum levels of total ghrelin and inflammatory markers TNF‑α 
and hsCRP in cases and control is given in Table 4. The levels 
of serum total ghrelin, TNF–α, and hsCRP were significantly 
elevated in the cases than the control (P < 0.001). The cases 
were further subjected to the following assessments.
Nutritional status based on subjective global 
assessment‑dialysis malnutrition score and appetite 
based on appetite and diet assessment tool
The SGA-DMS scores showed that 49/90 (54.4%) patients 
were moderate to severely malnourished with a score range 
of 21–35 (mean score 25.6 [3.8]), 28/90 (31%) patients 
were mild to moderately nourished with a score range of 
11–200 (mean score 14.5 [3.2]) and 13/90 (14.4%) patients 
were well-nourished with a score range of 7–10 (mean score 
8.9 [1.2]) [Table 5].
Based on the ADAT scores, the appetite was found to be very 
good for13/90 (14.4%) patients, of which 3 were severely 
malnourished, 5 patients were moderately nourished, and 5 
were well-malnourished. There were 43/90 (47.8%) patients 
with good and fair appetite, of which 16 were severely 
malnourished, 19 were moderately malnourished, and 8 were 
Table 2: Anthropometric data of cases and control





Height (cm) 157.9 (9.04) 161.7 (6.8) <0.01*
Body weight (kg) 53.7 (10.7) 64.2 (8.1) <0.001**
BMI (kg/m2) 21.5 (3.6) 24.54 (2.9) <0.001**
Mid arm 
circumference (cm)
20.06 (3.8) 24.82 (1.3) <0.001**
Mid arm muscle 
circumference (cm)
16.9 (2.8) 21.97 (1.5) <0.001**
Triceps skin fold 
thickness (mm)
9.54 (1.5) 10.20 (3.1) <0.001**
Mid arm muscle area (m2) 23.3 (7.3) 38.6 (5.9) <0.001**
Mid arm fat area (cm2) 9.9 (4.7) 11.25 (2.3) <0.001**
Lean body mass (kg) 43.8 (8.9) 49.1 (5.6) <0.001**
Ideal body mass (kg) 54.5 (7.9) 56.2 (8.3) 0.19 (NS)
Total body water (L) 31.1 (4.9) 34.7 (4.8) <0.001**
Fat free mass (kg/m2) 43.2 (6.9) 48.4 (6.7) <0.001**
Total body fat (kg) 10.5 (6.7) 16.3 (5.5) <0.01*
*Level of significance at P<0.05, **Level of significance at P<0.001, Values are expressed 
as means (SD). SD: Standard deviation, BMI: Body mass index, NS: Nonsignificant, 
n: Number of subjects






Hemoglobin (g%) 9.1 (1.4) 13.6 (2.6) <0.001**
Packed cell volume (%) 32.7 (4.9) 40.2 (4.3) <0.001**
Albumin (g/dL) 3.4 (0.5) 3.9 (0.3) <0.001**
Globulin (g/dL) 3.2 (0.4) 3.3 (0.4) 0.78 (NS)
Total protein (g/dL) 6.3 (0.7) 7.1 (0.5) <0.001**
Creatinine (mg/dL) 6.6 (2.9) 0.8 (0.1) <0.001**
eGFR (ml/min/1.73 m2) 9.9 (4.9) 103.7 (9.5) <0.001**
**Level of significance at P<0.001, Values are expressed as means (SD). SD: Standard 
deviation, NS: Nonsignificant, n: Number of subjects, eGFR: Estimated growth factor receptor
Table 4: Ghrelin and inflammatory markers in cases and 
control
Variables Cases (n=90) Control (n=70) t‑test (P)
Ghrelin (pg/ml) 242.5 (62.3) 80.7 (19.6) <0.001**
TNF‑α (pg/ml) 39.8 (15.2) 6.54 (1.2) <0.001**
hsCRP (mg/L) 10.2 (2.8) 2.7 (0.5) <0.001**
**Level of significance at P<0.001, Values are expressed as means (SD). SD: Standard 
deviation, n: Number of subjects, hsCRP: High‑sensitivity C‑reactive protein, TNF‑α: Tumor 
necrosis factor‑alpha
Table 5: Nutritional status assessment of cases based on 
subjective global assessment‑dialysis malnutrition score








Well nourished 7‑10 8.9 (1.2) 13 (14.4)
Mild to moderately 
malnourished
11‑20 14.5 (3.2) 28 (31.1)
Moderate to severely 
malnourished
21‑35 25.6 (3.8) 49 (54.4)
SGA: Subjective global assessment, DMS: Dialysis malnutrition score, SD: Standard 
deviation
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well-nourished. The appetite was found to be poor and very 
poor for 34/90 (37.8%) patients, of which 30 were severely 
malnourished and 4 patients were moderately malnourished. 
There was a statistically significant difference in the appetite 
of the hemodialysis patients based on their nutritional 
status (P < 0.001) as shown in Table 6. Poorer the nutritional 
status significantly poorer was the appetite.
Dialysis data and nutritional status
Table 7 explains the dialysis data of the case population with 
respect to their nutritional status. There was no significant 
difference in the dialysis vintage (P = 0.77), interdialytic 
weight gain (P = 0.93), dialysis adequacy (P = 0.48), 
nPCR (P = 0.6), URR (P = 0.53), and ultrafiltration (P = 0.75) 
in the case group based on their nutritional status.
The anthropometric indices of the study population based 
on their nutritional status are described in Table 8. There 
were no difference between the mean height (P = 0.92) of 
the case population based on their nutritional status. The 
mean dry body weight (P = 0.16), LBM (P = 0.14), ideal 
body mass (P = 0.79), TBW (P = 0.38), FFM (0.39), and the 
TBF (P = 0.26) were found to be higher in well-nourished 
patients than the moderately and severely malnourished 
patients but the differences were not statistically significant. 
The mean BMI (P = 0.02), TSF (P < 0.01), MAC (P < 0.001), 
MAMC (P < 0.01), MAMA (P < 0.001), and MAFA (P < 0.01) 
were also higher in well-nourished patients than the 
malnourished patients and the difference was statistically 
significant.
The biochemical parameters, serum total ghrelin, TNF-α, and 
hsCRP levels of the case population based on their nutritional 
status is explained in Table 9. There was a statistically 
significant decrease in the serum hemoglobin (P < 0.01), 
packed cell volume (P < 0.01), serum iron (P < 0.01), 
transferrin (P < 0.001), TIBC (P < 0.01), and the 
albumin (P < 0.001) levels with respect to decline in the 
nutritional status. However, serum ferritin (P < 0.01) levels 
were found to be significantly increased with thedecline in 
nutritional status since ferritin is an acute phase reactant 
which tends to increase in inflammation. There was no 
significant difference in the parameters such as serum 
globulin (P = 0.87), total protein (P = 0.12), creatinine (0.18), 
eGFR (P = 0.09), pre- and post-dialytic BUN levels (P = 0.28 
and 0.23, respectively) based on the nutritional status. 
The total ghrelin (P < 0.001), TNF-α (P < 0.001), and 
hsCRP levels (P = 0.02) were significantly increased in 
patients who were moderate to severely malnourished 
when compared to patients who were mild to moderately 
nourished and well-nourished. There was a positive correlation 
between serum ghrelin and TNF-α (r = 0.72; P < 0.001), 
ghrelin and hsCRP (r = 0.55; P < 0.001), ghrelin and the 
SGA-DMS (r = 0.72; P < 0.001). Similarly, there was a 
positive correlation between TNF-α and SGA-DMS (r = 0.63; 
P < 0.001) and hsCRP and SGA-DMS (r = 0.38; P < 0.001). 
The results indicated an increase in the levels of total ghrelin 
and inflammatory markers with an increase in the SGA‑DMS 
scores which reflected a decline in the nutritional status.
Discussion
Protein energy malnutrition PEM is widespread in patients 
with ESRD, adversely affecting their quality of life and also 
associated with increased mortality and morbidity. In light of 
the discovery of ghrelin, the orexigenic peptide and its role 
on appetite regulation and nutritional status, the present study 
had assessed whether the nutritional status and inflammation in 
ESRD patients on MHD was associated with altered regulation 
of serum levels of total ghrelin.
Table 6: Appetite and nutritional status of cases





Mild to moderately 
malnourished (n=28)
Moderate to severely 
malnourished (n=49)
Very good 5 5 3 13 (14.4) <0.001**
Good and fair 8 19 16 43 (47.8)
Poor and very poor 0 4 30 34 (37.8)
**Level of significance at P<0.001. n: Number of subjects, ANOVA: Analysis of variance
Table 7: Dialysis data versus nutritional status of cases
Dialysis data Well nourished 
(n=13)
Mild to moderately 
malnourished (n=28)
Moderate to severely 
malnourished (n=49)
ANOVA (P)
Dialysis vintage (months) 20.1 (13.2) 19.9 (11.1) 21.8 (12.5) 0.77 (NS)
Interdialytic weight gain (kg) 3.1 (1.3) 3.1 (1.1) 3.2 (1.2) 0.93 (NS)
Dialysis adequacy (Kt/V) 1.4 (0.1) 1.4 (0.1) 1.4 (0.9) 0.48 (NS)
nPCR (g/kg/day) 1.8 (0.4) 1.8 (0.5) 1.7 (0.4) 0.60 (NS)
URR 66.2 (2.2) 66.8 (2.7) 66.2 (2.3) 0.53 (NS)
Ultrafiltration (L) 3.6 (0.7) 3.7 (0.6) 3.6 (0.7) 0.75 (NS)
Values are expressed as means (SD). n: Number of subjects, NS: Nonsignificant, ANOVA: Analysis of variance, nPCR: Normalized protein catabolic rate, URR: Urea reduction rate, 
SD: Standard deviation
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Nutritional status assessment could be done by several 
methods ranging from anthropometric measurements to more 
elaborate techniques such as dual energy X-ray absorptiometry 
and biochemical parameters such as albumin, serum iron, 
transferrin, and ferritin. Though these biochemical parameters 
are extensively used to assess the nutritional status, they do 
not necessarily correlate with changes in other nutritional 
parameters and can be influenced by nonnutrition‑related 
factors.
The subjective methods for nutritional status assessment can 
be clinical history and physical examination, and objective 
methods include anthropometry, biochemical exams, and 
bioelectrical impedance.[31] SGA is a useful and reproducible 
instrument for assessing the nutritional status of dialysis 
patients. The National Kidney Foundation – Kidney Disease 
and Dialysis Outcomes Quality Initiative recommended the 
SGA-DMS as an appropriate nutritional assessment tool for 
dialysis patients as it correlates the subjective and objective 
aspects of medical history and physical examination.[32]
Anthropometry provides a semi-quantitative estimate of the 
components of body mass, particularly the bone, muscle, and 
fat compartments, and thus gives us information concerning 
nutritional status. In the present study, BMI, skinfold thickness, 
and the arm circumferences were the significant predictors of 
nutritional status when compared to the other anthropometric 
indices. Chen et al. demonstrated that BMI and MAC indicated 
the strong relationship with nutritional status, and they had 
better predictive value for nutritional status evaluation in 
comparison with the other anthropometric measurements.[33]
Detection of malnutrition in patients on MHD should be done 
as early as possible for prevention of severe consequences. 
Anthropometric measurements and SGA-DMS could have 
Table 8: Anthropometry and nutritional status of cases
Anthropometric indices Well nourished 
(n=13)
Mild to moderately 
malnourished (n=28)
Moderate to severely 
malnourished (n=49)
ANOVA (P)
Height (cm) 157.2 (10.3) 157.7 (7.7) 158.3 (9.6) 0.92 (NS)
Dry body weight (kg) 57.7 (10.0) 55.1 (8.0) 51.9 (11.9) 0.16 (NS)
BMI (kg/m2) 23.3 (3.4) 22.1 (2.6) 20.6 (3.6) 0.02*
Mid arm circumference (cm) 22.3 (2.3) 21.5 (1.9) 18.7 (4.3) < 0.001**
Mid arm muscle circumference (cm) 18.5 (1.5) 18.1 (1.5) 15.8 (3.2) <0.001**
Triceps skin fold thickness (mm) 12.0 (2.67) 10.9 (1.9) 9.3 (3.5) <0.01*
Mid arm muscle area (cm2) 27.4 (4.5) 26.1 (4.2) 20.59 (8.2) <0.001**
Mid arm fat area (cm2) 12.4 (3.9) 10.9 (2.8) 8.6 (4.8) <0.01*
Lean body mass (kg) 46.9 (6.3) 45.7 (6.9) 42.2 (9.2) 0.14 (NS)
Ideal body mass (kg) 55.0 (8.4) 54.4 (9.3) 53.7 (6.5) 0.78 (NS)
Total body water (L) 31.9 (3.9) 31.9 (4.4) 30.4 (5.5) 0.38 (NS)
Fat free mass (kg/m2) 44.3 (5.4) 44.29 (6.2) 42.3 (7.6) 0.39 (NS)
Total body fat (kg) 10.4 (3.4) 9.5 (2.2) 8.2 (2.4) 0.26 (NS)
*Level of significance at P<0.05, **Level of significance at P<0.001, Values are expressed as means (SD). n: Number of subjects, NS: Nonsignificant, ANOVA: Analysis of variance, BMI: Body 
mass index, SD: Standard deviation
Table 9: Biochemical parameters of cases versus nutritional status
Biochemical parameters Well nourished 
(n=13)
Mild to moderately 
malnourished (n=28)
Moderate to severely 
malnourished (n=49)
ANOVA (P)
Hemoglobin (g%) 10.2 (0.9) 9.9 (1.1) 9.02 (1.4) <0.01*
Packed cell volume (%) 35 (5.0) 34.3 (4.7) 31.1 (4.6) <0.01*
Serum iron 88.9 (32.7) 75.43 (24.4) 64.8 (17.8) <0.01*
Serum ferritin 261.4 (72.9) 277.5 (70.3) 374.2 (186.1) <0.01*
Serum transferrin 237.7 (35.2) 202.3 (35.9) 170.2 (39.1) <0.001**
TIBC 183.3 (11.2) 219.9 (81.8) 174.1 (37.5) <0.01*
Albumin (mg/dL) 3.4 (0.6) 3.7 (0.3) 3.3 (0.4) <0.001**
Globulin (mg/dL) 3.2 (0.2) 3.3 (0.3) 3.2 (0.4) 0.87 (NS)
Total protein (mg/dL) 6.3 (0.6) 6.5 (0.7) 6.2 (0.7) 0.12 (NS)
Creatinine (mg/dL) 6.3 (2.3) 6.6 (3.4) 7.9 (3.9) 0.18 (NS)
eGFR (ml/min/1.73 m2) 7.2 (2.8) 10.1 (4.4) 10.8 (6.1) 0.09 (NS)
Predialytic BUN 116 (33.9) 121.2 (40.7) 133.9 (31.8) 0.28 (NS)
Postdialytic BUN 38.7 (11.0) 40.5 (14.4) 45.15 (10.9) 0.23 (NS)
Ghrelin (pg/ml) 112.3 (27.5) 182.57 (31.9) 256.45 (38.9) <0.001**
TNF‑α (pg/ml) 30.7 (11.1) 33.6 (11.7) 45.8 (15.5) <0.001**
hsCRP (mg/L) 9.12 (2.3) 9.8 (2.7) 10.6 (2.9) 0.02*
*Level of significance at P<0.05, **Level of significance at P<0.001. Values are expressed as means (SD). n: Number of subjects, NS: Nonsignificant, ANOVA: Analysis of variance, TIBC: Total 
iron binding capacity, SD: Standard deviation, BUN: Blood urea nitrogen, hsCRP: High‑sensitivity C‑reactive protein, TNF‑α: Tumor necrosis factor‑alpha, eGFR: Estimated growth factor receptor
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great value in early detection especially in HD units with 
limited financial recourses.
The presence of anorexia and its degree can be evaluated 
through the ADAT. In the ADAT designed by Burrowes et al. 
and used in the HEMO trial, the initial three questions relate to 
appetite. In the HEMO trial, patients who ranked their appetite 
as poor or very poor had serum albumin levels, nPCR, and 
serum creatinine concentrations that were significantly lower 
than those in patients who ranked their appetite as very good, 
good, or fair. The study also demonstrated that ADAT can be 
used in clinical practice to assess the effects of changes in the 
patient’s medical condition, which may have an impact on 
appetite and nutritional status.[34]
To our knowledge, the ADAT was not used in Indian 
population. Hence, in the present study, only five questions 
of the ADAT were used to assess the self-reported appetite 
of the patients. Unlike other items in the ADAT, these five 
questions directly reflect on the appetite changes and may not 
be affected by cultural and ethnic variations of the population. 
Further studies are needed to validate the applicability of entire 
ADAT in Indian population.
The serum total ghrelin, TNF-α, and hsCRP levels were found 
to be significantly high in the MHD patients when compared to 
the healthy individuals. There was a positive correlation between 
total ghrelin and the inflammatory markers. Mafra et al.[35,36] in 
their studies have also reported a high levels of fasting serum 
total ghrelin levels in MHD patients and its positive correlation 
with the inflammatory markers TNF‑α and IL-6.
A study done by Kandil et al.[37] also reported a marked 
increase in plasma total ghrelin levels in chronic hemodialysis 
patients and a moderate increase in predialysis patients 
compared to healthy control group. Carrero et al.[6] reported 
markedly elevated plasma total ghrelin levels in ESRD 
patients treated by HD when compared with normal control. 
Rodriguez Ayala etal.[38] have also reported a significantly 
higher total ghrelin levels in MHD Patients. In contrast to 
the strong tendency for anorexia in MHD, the increase in 
the total ghrelin levels in ESRD patients may result from 
decreased degradation or elimination of ghrelin in the kidney 
or may be overproduction of ghrelin in organs other than the 
stomach and also may be attributable to different basal levels 
in different races.Chang et al.[39] have reported an increase 
in the plasma levels of ghrelin in MHD patients than the 
healthy control suggesting ghrelin resistance in MHD either 
peripheral, central, or both.
In the present study, the anthropometric indices and the 
biochemical markers hemoglobin, packed cell volume, and 
albumin were also decreased in the case group when compared 
to the control group thus reflecting the compromised nutritional 
status of the MHD patients. These observations are similar to 
other research.[40]
Based on SGA-DMS scores of the 90 patients on MHD, 
54.4% patients were moderate to severely malnourished and 
31.1% were mild to moderately malnourished. Studies done 
by Tapiawala et al.[41] and Prakash et al.[42] have also reported 
a 50–65% prevalence of mild to severe malnutrition in Indian 
population with ESRD. The prevalence is slightly higher in 
Indian patients than the Western world (10–54%). The reasons 
for the higher prevalence of malnutrition in Indian population 
could be possibly due to poor socioeconomic status and related 
consequences such as the inability to afford to adequate renal 
nutrition.
In the present study, the self-reported appetite had a strong 
association with nutritional status. Patients who were 
well-nourished had a very good appetite when compared to 
patients with moderate to severe malnutrition. Considering 
that lack of appetite is one of the manifestations of uremia, it 
seems plausible to expect that this symptom may be improved 
by increasing the dialysis adequacy.[34] In the present study, 
the dialysis adequacy (Kt/V) was found to be at a correct 
dose, but it did not have a significant effect on the appetite 
and the nutritional status of the MHD patients. Similarly, 
other dialysis-dependent parameters such as nPCR, URR, 
ultrafiltration, and dialysis vintage had no significant effect 
on the nutritional status. Lopes et al.[43] have also reported the 
lack of association between lack of appetite, Kt/V, dialysis 
vintage, and other dialysis-related factors. In contrast to this, 
studies have also reported a strong association between loss 
of appetite, malnutrition, and dialysis-related factors such 
as dialysis vintage, dialysis dose (Kt/V), URR, and protein 
catabolic ratio.[44]
The present study had also identified a strong positive 
correlation with serum total ghrelin levels, and the SGA-DMS 
scores indicating that the ghrelin levels were significantly 
high in moderate to severely malnourished patients 
than the mild to moderate and well-nourished patients. 
Similarly, higher was the total ghrelin levels higher were 
the inflammatory markers TNF‑α and hsCRP. This finding 
suggests a strong correlation between serum total ghrelin, 
inflammation, and the nutritional status. Given the fact 
that ghrelin is an orexigenic hormone and inflammation 
is associated with renal anorexia, it is reasonable to 
discussPharmacovigilance reporting databases, Signal 
detection and Management the role of desacylghrelin, 
which was previously reported to be a prime factor in renal 
patients on inflammatory anorexia. Since desacyl ghrelin 
is the major form of total circulating ghrelin and this form 
could significantly reduce appetite in these patients, the 
assumption that inflammation causes elevation of total 
ghrelin may be viable.Muscaritoli et al.[45] also suggests 
that the desacyl form of ghrelin could be involved in the 
pathogenesis of anorexia in MHD patients.
Study evaluating inflammation and ghrelin in non‑CKD 
patients has shown that ghrelin levels seem to be elevated 
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in inflammation. In addition, endotoxins and cytokines 
modulate serum ghrelin levels in a different manner 
depending on the time course.[46] Vila et al.[47] reported 
an acute surge in the circulating total ghrelin levels at 
120 min following the administration of Escherichia coli 
endotoxin (lipopolysaccharide) in humans, along with the 
release of inflammatory mediators TNF‑α and IL-6. Hence, 
they suggested that ghrelin was one of the hormones secreted 
initially in response to bacterial endotoxic shock in humans. 
Though there are presently conflicting information regarding 
the association between total ghrelin and markers of chronic 
inflammation, these reports hypothesized that ghrelin could 
have anti-inflammatory effects, and it is likely that the 
elevation of serum ghrelin concentrations in inflammation 
is one of the defense mechanisms against the overshooting 
of inflammation. These authors concluded that increased 
ghrelin may represent a compensatory mechanism under 
catabolic–anabolic imbalance in the ESRD patients.
In the present study, patients with high TNF-α and hsCRP 
levels had poor nutritional status and a poor appetite suggesting 
that systemic inflammation in MHD patients could lead to 
reduced appetite, which is also contributed by high total ghrelin 
levels (predominantly due to desacyl ghrelin which forms a 
major portion of total ghrelin).
Conclusion
The present study substantiates the prevalence of 
malnutrition and anorexia in patients on MHD and had 
shed light on the association of total ghrelin with their 
nutritional and inflammatory status. Since malnutrition and 
inflammation has a significant impact on the prognostic 
outcome of dialysis patients, nutritional assessment, and 
management of malnutrition‑inflammation complex appears 
to be of prime importance. Ghrelin emerges as a promising 
biomarker of cachexic malnutrition‑inflammation complex 
in patients on MHD. Further studies are warranted in 
larger population to corroborate the aforementioned role 
of ghrelin.
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